External research collaboration drives AI device introductions, especially for small firms.

It is hard to tell if artificial intelligence helps companies make money because finding who actually builds AI into real products is difficult. Medical technology is different. Companies must get official clearance from health authorities before selling AI medical tools, creating a clear public paper trail. Researchers tracked this process by linking records of approved devices, patents, research papers, and company finances. They mapped out how working with outside partners leads to new AI tools, and how those tools affect company success. They found that teaming up with outside research partners helps companies launch AI devices, especially small firms with limited internal research teams. Partnerships with other businesses and medical clinics helped the most, while university ties helped the least. Bringing an AI device to market raised worker productivity, building up with each new release. However, boosts to profit margins were weaker and less consistent, likely because competition reduces pricing power.

Why it matters

For medical device firms, this study shows that external research collaborations are crucial for bringing AI devices to market, especially for smaller companies that lack internal R&D capacity. It also reveals that while AI devices boost worker productivity, they may not increase profit margins due to competitive pressures. This helps firms and investors understand where AI investments truly pay off.

Questions answered